ClinicalTrials.govpublic full text
Eculizumab for Prevention of Antibody-Mediated Rejection in ABO-Incompatible Living Donor Kidney Transplantation
kidney transplantation, eculizumab, antibody-mediated rejection, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 910875
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.